FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ribavirin (Rebetol) Oral Solution
Status: Discontinuation
»Therapeutic Categories: Antiviral

Merck Sharp & Dohme Corp. (New 04/16/2019)

Company Contact Information:
800-672-6372

Presentation Posting Date Related Information
40 mg/mL (NDC 0085-1318-01) 04/16/2019 To be discontinued on or near June 2019.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English